Insiders · Profile

Bulis Veronica Sanchez

VP, Corporate Controller at Lyell Immunopharma. Filing since 10 Nov 2025. CIK 0002095702

Company
Date
Role
Action
Shares
Amount
Of holding
10 Aug 2026
VP, Corporate Controller
Sold at will
621
$8.91K
4.0%
11 May 2026
VP, Corporate Controller
Sold at will
217
$4.10K
1.4%
10 Feb 2026
VP, Corporate Controller
Sold at will
254
$5.87K
1.6%
30 Dec 2025
VP, Corporate Controller
Sold at will
936
$30.25K
11.6%
24 Dec 2025
VP, Corporate Controller
Sold at will
1,136
$43.93K
12.3%
10 Nov 2025
VP, Corporate Controller
Sold at will
239
$3.85K
2.5%
6 decisions on file.